This new scan finds prostate cancer spread better than old ones

Original Title

Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Doctors use scans to see if prostate cancer has spread to nearby lymph nodes. This new scan (PSMA PET/CT) finds more cancer than older scans like MRI and CT.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Whole-body MRI, often considered the gold standard for soft tissue imaging, had a 55% false-negative rate for lymph node metastases.

MRI is widely trusted for detecting tumors and soft tissue changes. Finding it misses more than half of cancerous nodes in prostate cancer contradicts its assumed superiority over CT.

Practical Takeaways

If you or a loved one has high-risk prostate cancer, ask your oncologist: 'Can we do a PSMA PET/CT scan for staging?' — especially if MRI or CT came back negative.

high confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

52%
Moderate QualityOverall Score

Publication

Journal

European Journal of Nuclear Medicine and Molecular Imaging

Year

2021

Authors

S. Malaspina, M. Anttinen, P. Taimen, I. Jambor, M. Sandell, I. Rinta-Kiikka, S. Kajander, J. Schildt, E. Saukko, T. Noponen, J. Saunavaara, P. Dean, R. Sequeiros, H. Aronen, J. Kemppainen, M. Seppänen, P. Boström, O. Ettala

Open Access
43 citations
Analysis v1